Skip to main content

Country Hub

  • Country portal

Secondary nav

  • Gavi's next strategic period
  • #ForOurFuture
  • Ethics Hotline
  • English
  • Français
Home

Main navigation

  • Our Alliance
    About
    • Mission & vision
    • Our impact
    • Leadership
    Strategy
    • Current (2021–2025)
    • Next (2026–2030)
    • Vaccine Investment Strategy 2024
    • Risk management
    • Learning System Strategy
    • Gender & immunisation
    • Climate, health & immunisation
    Operating model
    • Our partners
    • Business model
    • People & leadership
    • Data & transparency
    Governance
    • Gavi Board
    • Governance & legal structures
    • Board & Committee minutes
    • Corporate Policies
    • Audit & investigations
    Market Shaping
    • Vaccine Innovation Prioritisation Strategy (VIPS)
    • Vaccine demand forecasting
    • Roadmaps
    • Product information: vaccines & cold chain equipment
    Global health & development
    • Sustainable Development Goals
    • International Health Partnership for UHC 2030
    • Decade of Vaccines Collaboration
    • Millennium Development Goals
    Work with us
    • Vacancies
    • Internships
    • RFPs & consulting opportunities

    Contact us ISO certification Phishing & fraud

    • About
      • Mission & vision
      • Our impact
      • Leadership
    • Strategy
      • Current (2021–2025)
      • Next (2026–2030)
      • Vaccine Investment Strategy 2024
      • Risk management
      • Learning System Strategy
      • Gender & immunisation
      • Climate, health & immunisation
    • Operating model
      • Our partners
      • Business model
      • People & leadership
      • Data & transparency
    • Governance
      • Gavi Board
      • Governance & legal structures
      • Board & Committee minutes
      • Corporate Policies
      • Audit & investigations
    • Market Shaping
      • Vaccine Innovation Prioritisation Strategy (VIPS)
      • Vaccine demand forecasting
      • Roadmaps
      • Product information: vaccines & cold chain equipment
    • Global health & development
      • Sustainable Development Goals
      • International Health Partnership for UHC 2030
      • Decade of Vaccines Collaboration
      • Millennium Development Goals
    • Work with us
      • Vacancies
      • Internships
      • RFPs & consulting opportunities

    Contact us ISO certification Phishing & fraud

  • Programmes & Impact
    How our support works
    • Support guidelines
    • Independent Review Committee
    • Joint appraisals
    • Country portal
    Programmatic support
    • Vaccine support
    • Funding for civil society organisations (CSOs)
    • Health systems & immunisation strengthening
    • Partners' Engagement Framework (PEF)
    • Global health security
    Regional manufacturing strategy
    • Overview
    • African Vaccine Manufacturing Accelerator (AVMA)
    • Vaccine market dashboard
    Country Hub
    • All countries
    • Africa
    • Americas
    • Eastern Mediterranean
    • Europe
    • South-East Asia
    • Western Pacific
    Our impact
    • Progress reports
    • Facts & figures
    • Digital health information (DHI)
    • Measuring our performance
    • Evaluation studies
    Programmatic policies
    • Eligibility & co-financing policies
    • Fragility, emergencies & displaced populations policy
    • Gender policy
    • Health systems & immunisation strengthening policy
    • Prioritisation mechanism
    • Risk policy
    • Self-procurement policy
    • Transparency & accountability
    • Vaccine donation policy

    About Gavi Facts & figures Contact us

    • How our support works
      • Support guidelines
      • Independent Review Committee
      • Joint appraisals
      • Country portal
    • Programmatic support
      • Vaccine support
      • Funding for civil society organisations (CSOs)
      • Health systems & immunisation strengthening
      • Partners' Engagement Framework (PEF)
      • Global health security
    • Regional manufacturing strategy
      • Overview
      • African Vaccine Manufacturing Accelerator (AVMA)
      • Vaccine market dashboard
    • Country Hub
      • All countries
      • Africa
      • Americas
      • Eastern Mediterranean
      • Europe
      • South-East Asia
      • Western Pacific
    • Our impact
      • Progress reports
      • Facts & figures
      • Digital health information (DHI)
      • Measuring our performance
      • Evaluation studies
    • Programmatic policies
      • Eligibility & co-financing policies
      • Fragility, emergencies & displaced populations policy
      • Gender policy
      • Health systems & immunisation strengthening policy
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency & accountability
      • Vaccine donation policy

    About Gavi Facts & figures Contact us

  • Investing in Gavi
    Resource mobilisation
    • Global Summit: Health & Prosperity through Immunisation
    • Process
    Funding
    • Overview 2000–2037
    Our donors
    • Donor governments and the European Union
    • Foundations, corporations, institutions and organisations
    Partnering with business
    • Partnership types
    • Why partner with Gavi
    Innovative financing
    • International Finance Facility for Immunisation (IFFIm)
    • Pneumococcal Advance Market Commitment (AMC)
    • Gavi Matching Fund
    • Loan buydown
    INFUSE
    • INFUSE community
    • Call for innovations

    Strategic finance

    Innovative financing

    As part of our long-term funding and private sector engagement strategy, we use innovative finance mechanisms to incentivise investment in immunisation.

    Learn more

    Key publication

    IO


    Gavi's Investment Opportunity 
    2026–2030

    Download

    Global Summit, 25 June 2025

    • Resource mobilisation
      • Global Summit: Health & Prosperity through Immunisation
      • Process
    • Funding
      • Overview 2000–2037
    • Our donors
      • Donor governments and the European Union
      • Foundations, corporations, institutions and organisations
    • Partnering with business
      • Partnership types
      • Why partner with Gavi
    • Innovative financing
      • International Finance Facility for Immunisation (IFFIm)
      • Pneumococcal Advance Market Commitment (AMC)
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    Global Summit, 25 June 2025

  • VaccinesWork
    Topics
    • Stories from the community
    • Emerging threats
    • News from the lab
    • Tales from the past
    • Vaccine profiles
    • Gavi matters
    VaccinesWork

     

    VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.

    About | Homepage

    A child held by its mother after receiving the necessary doses of vaccines as part of the Reach Zero Dose Children (ZDC) campaign in Somalia. Credit: Gavi/2024/Mohamed Abdihakim Ali
    Why millions of children still miss life-saving vaccines 22 Aug 2025
    Community Health Promoters from Busia County pose with their bicycles. Credit: Living Goods
    In western Kenya, bicycles are changing healthcare 22 Aug 2025
    All of the Chikungunya cases in England were associated with travel to regions which have had ongoing outbreaks of the virus. nechaevkon/ Shutterstock
    Chikungunya: what travellers should know about this mosquito-borne virus 22 Aug 2025

    Latest VaccinesWork About VaccinesWork Contact the Editor

    • Topics
      • Stories from the community
      • Emerging threats
      • News from the lab
      • Tales from the past
      • Vaccine profiles
      • Gavi matters

    Latest VaccinesWork About VaccinesWork Contact the Editor

  • News & resources
    Media room
    • News releases
    • Media contacts
    • Media resources
    Resources
    • Knowledge products
    • Communication toolkits
    • Leadership biographies
    • Progress reports
    • Publications
    Document library
    • Board & Committee minutes
    • Evaluations
    • Independent Review Committee (IRC) reports
    • Financial reports

    Latest insights

    Polio vaccinators. Credit: UNICEF/ACQUAH

    How we fight disease outbreaks: first-hand accounts from the epidemic frontlines

    Learn more

    News releases

    Gavi news releases


    View all our news releases to read the latest announcements

    View news releases

    About Gavi Facts & figures Contact us

    • Media room
      • News releases
      • Media contacts
      • Media resources
    • Resources
      • Knowledge products
      • Communication toolkits
      • Leadership biographies
      • Progress reports
      • Publications
    • Document library
      • Board & Committee minutes
      • Evaluations
      • Independent Review Committee (IRC) reports
      • Financial reports

    About Gavi Facts & figures Contact us

    • Country portal
    • Gavi's next strategic period
    • #ForOurFuture
    • Ethics Hotline
    • English
    • Français
 

  • English
  • Français
  • Home
  • News and resources
  • Media room
  • Statements
Back to

Statements

28 July 2013

Price reduced for vaccine against pneumococcal disease

Price reduced for vaccine against pneumococcal disease
Read more

25 July 2013

Research shows high impact of Hib vaccines in developing countries

Research shows high impact of Hib vaccines in developing countries
Read more

18 July 2013

UK Government recognises GAVI's progress

UK Government recognises GAVI's progress
Read more

12 June 2013

GAVI Board asks to begin preparations for introduction of inactivated polio vaccine and considers investment in other new vaccines

Read more

30 May 2013

GAVI Alliance welcomes priority given to health and immunisation in High Level Panel Report

GAVI Alliance welcomes priority given to health and immunisation in High Level Panel Report
Read more

14 May 2013

Rotavirus leading cause of diarrhoea

Rotavirus leading cause of diarrhoea
Read more

12 April 2013

Immunisation one key intervention to end two million preventable child deaths each year

Immunisation one key intervention to end two million preventable child deaths each year
Read more

11 April 2013

GAVI review of health system strengthening in Sierra Leone

GAVI review of health system strengthening in Sierra Leone
Read more

7 March 2013

Stronger protection for women and girls' health starts today

Stronger protection for women and girls' health starts today
Read more

25 February 2013

Statement on Ms Zainab Bangura and GAVI’s review of Sierra Leone

Statement on Ms Zainab Bangura and GAVI’s review of Sierra Leone
Read more

11 February 2013

Attacks on health workers in Nigeria unacceptable

Attacks on health workers in Nigeria unacceptable
Read more

30 January 2013

Simon Lamb appointed head of GAVI Internal Audit

Simon Lamb appointed head of GAVI Internal Audit
Read more

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • …
  • Next page Next ›
  • Last page Last »
Last updated: 25 Nov 2019
Home

Footer

  • Our Alliance
  • Programmes & impact
  • Investing in Gavi
  • VaccinesWork
  • News & resources

Country Hub

  • Country portal

Donate

  • #ForOurFuture
  • Donate

Footer nav

  • Careers
  • Contact
  • Ethics hotline
  • IFFIm
  • Privacy notice
  • Terms of use
  • Phishing and fraud

© Gavi 2025

  • Gavi LinkedIn
  • Gavi Twitter
  • Gavi Instagram
  • Gavi Facebook
  • Gavi YouTube
  • Gavi TikTok
VSN logoCAF International logo

Our achievements are thanks to the support and expertise of our founding partners

  • English
  • Français